We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

EUROIMMUN AG

EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy and molecula... read more Featured Products: More products

Download Mobile App




Novel ELISA Detects Invasive Aspergillosis

By LabMedica International staff writers
Posted on 05 Sep 2019
Aspergillus spp. More...
is a ubiquitous sac fungus, which is found in soil or compost or on damp walls. Inhalation of spores can lead to severe infections in individuals with a weakened immune system.

In invasive aspergillosis (IA) the fungus spreads from the lungs to other parts of the body such as the nervous system, eyes, heart, kidneys and skin. Infections affecting the nervous system are nearly always fatal. Patients with neutropenia, leukaemia, or septic granulomatosis are especially at risk of IA.

Invasive aspergillosis is also a frequent complication in advanced AIDS or following chemotherapy or bone marrow or organ transplants. Early diagnosis and prompt treatment are crucial for survival. Since clinical and radiological signs of IA are often non-specific, additional diagnostics tests such as antigen detection and culture are nearly always required to substantiate diagnosis.

A CE-marked assay, Aspergillus Antigen ELISA (EUROIMMUN, Luebeck, Germany) is based on a monoclonal antibody for the detection of the Aspergillus-specific galactomannoprotein, which is produced during active fungal growth. The analysis is performed on patient serum or bronchoalveolar lavage (BAL) fluid. Results can be evaluated either quantitatively in pg/mL using a six-point calibration curve or semi-quantitatively by means of a cut-off ratio. Semi-automated processing is available, for example using the EUROIMMUN Analyzer I.

In the most comprehensive clinical study to date, carried out by the Ludwig-Maximilians-Universität München (Munich, Germany) based on 120 sera from 45 patients with proven IA as well as control sera, the EUROIMMUN Aspergillus Antigen ELISA yielded comparable sensitivity and specificity to another commercially available Aspergillus antigen test the Platelia Aspergillus Ag Assay. The EUROIMMUN assay identified 56% of the cases, while the Bio-Rad test detected 47%. The specificity amounted to 97% for the EUROIMMUN assay and 99% for the Bio-Rad test. To overcome the relatively low sensitivity of Aspergillus antigen detection, the authors recommend serial testing of patients at risk. The original study was published on June 25, 2019, in the Journal of Clinical Microbiology.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PlGF Test
Quidel Triage PlGF Test
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.